Duromine and type 2 diabetes

Obesity and overweight are two main risk factors of type 2 diabetes.

Statistically, each fourth obese Australian (BMI 30+) and each fifth overweight Australian (BMI 25 to 29.9) is diagnosed type 2 diabetes.

Experimental research have shown that healthy diet and physical activity can delay or even prevent the diabetes.

It is noteworthy that a low-calorie diet and physical activity are not only necessary for obesity and diabetes prevention.

Thanks to a healthy diet and regular physical exertion, people can prevent many other chronic medical conditions (atherosclerosis, hypertension and heart failure).

No less important fact is that obese patients avoid the occurrence of diabetic complications (e.g. blindness, chronic skin ulcer and neuropathy), when preventing the diabetes.

Thus, the diet and physical activity help to lose weight, normalize metabolism, improving glucose tolerance and maintaining good health.

In case non-drug methods of obesity treatment do not help to lose the body weight, Australian people are prescribed Duromine diet pills.

These pills suppress appetite effectively and help to increase thermogenesis.

You can get Duromine 15mg pills, 30mg or 40mg pills in Australian pharmacies.

This slimming medication is often prescribed to diabetic and non-diabetic patients with BMI 25+.

These weight loss pills do not affect safety and effectiveness of antidiabetic drugs.

Therefore, there is no need to adjust the daily doses of antidiabetic drugs after adding Duromine pills into antidiabetic therapy.

Change in dosing of drugs for diabetes treatment is needed if Duromine or non-drug anti-obesity therapy provide a significant weight loss.

Because of weight loss, diabetic patients may have:

  • Increased tissue sensitivity to insulin,
  • Reduced blood sugar levels,
  • Increased insulin secretion.

Diabetic patients, who are taking Duromine, must control their blood sugar regularly.

When the body weight starts to drop quickly after the use of this appetite suppressant, patient should immediately tell his therapist about his results.

Clinically significant weight loss may require the change of daily doses of:

  • Meglitinides (Novonorm)*
  • Metformin (Avandamet)*
  • Pramlintide (analogue of human amylin)**
  • Exenatide (Bydureon, Byetta)*
  • Insulin and insulin analogues (Acrapid, Apidra, Humalog)*.

DPP4 inhibitors (Xiliarx, Velmetia, Sobrea, Juvicor, Januvia, Janumet, Galvus, Galvumet)*
PPAR agonists (Acpio, Actos, Atilos, Avandamet, Avandia, Glitos, Litazone, Pioglitazone)*
Sulfonylureas (Amaryl, Alide, Daonil, Diabinese, Diamicron, Dianorm, Diapride, Diavance, Dimirel, Gliclazide, Glimel, Glimepiride, Glipidiab, Glipizide, Glucovance, Glyade, Melizide, Minidiab, Nidem, Semi-Daonil)*

  • (…)* Trade names in Australia
  • (…)** Not sold in Australia.